Placenta mesenchymal stem cell effects on mustard gas victims lung

Placenta mesenchymal stem cell effects on lung in veterans exposed to mustard gas

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015072223298N1

Enrollment

Registered

2015-12-17

Start date

2015-12-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung injury in sulfur mustard victims. Chronic respiratory conditions due to chemicals, gases, fumes and vapours, Other respiratory conditions due to chemicals, gases, fumes and vapours

Interventions

Drug: Placenta Placenta mesenchymal stem cell Dosage: 100 million cells per patient frequency: 4 times Duration: 15 days interval Injection method: vein injection.

Treatment - Other

Drug: Placenta Placenta mesenchymal stem cell Dosage: 100 million cells per patient frequency: 4 times Duration: 15 days interval Injection method: vein injection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients with a proven track record have mustard gas; Signed informed consent Exclusion criteria: Underlying disease

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Quality of life. Timepoint: In enrolment stage and 6 months after the first cell injection. Method of measurement: St. George's questionnaire form.	—

Secondary

Measure	Time frame
Spirometry factors. Timepoint: Befor each cell injection and 3 and 6 months after the first cel injection. Method of measurement: spirometry.;Repair and inflammation factors of lung. Timepoint: In enrolment stage and 3 and 6 months after the first cell injection. Method of measurement: ELISA method.;HRCT findings. Timepoint: In enrolment stage and months after the first cell injection. Method of measurement: HRCT imaging.	—

Measure

Time frame

Spirometry factors. Timepoint: Befor each cell injection and 3 and 6 months after the first cel injection. Method of measurement: spirometry.;Repair and inflammation factors of lung. Timepoint: In enrolment stage and 3 and 6 months after the first cell injection. Method of measurement: ELISA method.;HRCT findings. Timepoint: In enrolment stage and months after the first cell injection. Method of measurement: HRCT imaging.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarzad Parvizpour

Tehran University of Medical Sciences

f-parvizpour@razi.tums.ac.ir+98 21 8490 2172

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026